Stock Options Watch: YHOO, GILD, LINTA
GILD – Gilead Sciences, Inc. – Positive results from a Phase 3 study of Hepatitis C drug, sofosbuvir, pushed shares in Gilead are up more than 3.0% this morning to a new all-time high of $43.04 after the company said in a press release that it is “on track to meet its goal of filing [...] View the full post at: Stock Options Watch: YHOO, GILD, LINTA Related posts: Watch Out Big Tobacco: The Next Big Story Stock Could Be Here How to Take Advantage of a Bull Market in Volatility Sirius Stock Up as CEO Buys Two Million Shares
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here